2002

Wu, B.; Karle, J. M.; Watkins, E. B.; Avery, M. A. Toward the total synthesis of pseudolaric acid B. Preparation of a key intermediate by degradation and its use in the reassembly of the natural product. Tetrahedron Letters 2002, 43, 4095-4098.

Vyas, N.; Avery, B. A.; Avery, M. A.; Wyandt, C. M. Carrier-mediated partitioning of artemisinin into Plasmodium falciparum-infested erythrocytes. Antimicrobial Agents and Chemotherapy 2002, 46, 105-109.

Sabnis, Y.; Rosenthal, P. J.; Desai, P.; Avery, M. A. Homology modeling of falcipain-2: validation, de novo ligand design and synthesis of novel inhibitors. Journal of Biomolecular Structure & Dynamics 2002, 19, 765-774.

Sabnis, Y. A.; Desai, P. V.; Avery, M. A. Comparative protein structure modeling of falcipain-3: A novel cysteine protease from Plasmodium falciparum. Abstracts of Papers, 224th ACS National Meeting, Boston, MA, United States, August 18-22, 2002 2002, MEDI-063.

Pershadsingh, H. A.; Avery, M. A. Preparation of dithiolanyl thiazolidinediones as peroxisome proliferator-activated receptor .gamma. activators. In U.S.; (University of Mississippi, USA). Us, 2002; pp 38 pp., Cont.-in-part of U. S. Ser. No. 36,204,288.

Muri, E. M. F.; Mirshra, H.; Avery, M. A.; Williamson, J. S. Design and synthesis of heterocyclic hydroxamic acid derivatives as Helicobacter pylori urease inhibitors. Abstracts of Papers, 223rd ACS National Meeting, Orlando, FL, United States, April 7-11, 2002 2002, MEDI-168.

Mineno, T.; Stanford, K. M.; Walker, L. A.; Avery, M. A. Solution-Phase Parallel Synthesis of an Isoflavone Library for the Discovery of Novel Antigiardial Agents. Combinatorial Chemistry & High Throughput Screening 2002, 5, 481-487.

Mineno, T.; Choi, S.-R.; Avery, M. A. A mild deprotection of trichloroethyl carbamates using indium metal. Synlett 2002, 883-886.

Lima, P. d. C.; Barreiro, E. J.; Avery, M. A. Malarial cysteine protease inhibitors based on mefloquine and chloroquine. Abstracts of Papers, 223rd ACS National Meeting, Orlando, FL, United States, April 7-11, 2002 2002, MEDI-176.

Jung, J.-C.; Watkins, E. B.; Avery, M. A. Synthesis of 3-substituted and 3,4-disubstituted pyrazolin-5-ones. Tetrahedron 2002, 58, 3639-3646.

Jardat, M. S.; Noonan, D. J.; Wu, B.; Avery, M. A.; Feller, D. R. Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists. Planta Medica 2002, 68, 667-671.

Fiaux de Medeiros, S.; Avery, M. A.; Avery, B.; Leite, S. G. F.; Freitas, A. C. C. et al. Biotransformation of 10-deoxoartemisinin to its 7.beta.-hydroxy derivative by Mucor ramannianus. Biotechnology Letters 2002, 24, 937-941.

El Sayed, K. A.; Yousaf, M.; Hamann, M. T.; Avery, M. A.; Kelly, M. et al. Microbial and Chemical Transformation Studies of the Bioactive Marine Sesquiterpenes (S)-(+)-Curcuphenol and -Curcudiol Isolated from a Deep Reef Collection of the Jamaican Sponge Didiscus oxeata. Journal of Natural Products 2002, ACS ASAP.

El Sayed, K. A.; Orabi, K. Y.; Dunbar, D. C.; Hamann, M. T.; Avery, M. A. et al. Transformation of lactone to lactam in sarcophine and antimalarial activity of the resulting N-substituted azasarcophines. Tetrahedron 2002, 58, 3699-3708.

Avery, M. A.; Alvim-Gaston, M.; Vroman, J. A.; Wu, B.; Ager, A. et al. Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 7. Direct Modification of (+)-Artemisinin and In Vivo Antimalarial Screening of New, Potential Preclinical Antimalarial Candidates. Journal of Medicinal Chemistry 2002, 45, 4321-4335.

Avery, M. A.; Alvim-Gaston, M.; Rodrigues, C. R.; Barreiro, E. J.; Cohen, F. E. et al. Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 6. The Development of Predictive In Vitro Potency Models Using CoMFA and HQSAR Methodologies. Journal of Medicinal Chemistry 2002, 45, 292-303.

Avery, M. A.; Pershadsingh, H. A. Novel antioxidants. In U.S. Pat. Appl. Publ.; (USA). Us, 2002; pp 56 pp.

Avery, M. A. Methods of preparing epothilones and related analogs. In PCT Int. Appl.; (The University of Mississipi, USA). Wo, 2002; pp 129 pp.